Abstract:Introduction Gene‐corrected autologous cells provide one avenue for treating respiratory diseases, such as Cystic Fibrosis and Primary Ciliary Dyskinesia that harbor an underlying genetic defect. Basal cells are critical stem cells in the airways with the capacity to generate all cells of the respiratory epithelium. Use of these cells is limited due to inherent difficulties in gene editing and expansion in vitro . Efficient generation of basal cells from iPSCs has the potential to generate enough cells for both autologous cell therapy and for in vitro disease modelling. Building on our airway differentiation protocol, we have derived a strategy for the specification, isolation and expansion of iPSC‐derived basal cells (iBasal) improving the efficiency of generating respiratory epithelium from iPSC. Methods iPSC are cultured using a modified differentiation protocol pushing the formation of lung progenitor cells sorted on day 17 of differentiation for CD47 hi CD26 lo cells. These cells express transcription factor NKx2.1 and can be cultured in defined serum‐free media in the absence of wnt signaling. Over 4 passages we evaluated; 1) expression of basal cell markers, 2) clonality by a limited dilution clonogenic assay and by spheroid formation and 3) stem cell potential in spheroid and air‐liquid interface differentiation assays. Gene expression was compared to that of primary endogenous basal cells by bulk and single cell RNAseq, and validated by qPCR. Results Under our defined culture conditions, iBasal can be derived from NKx2.1 expressing lung progenitor cells. They are clonogenic forming colonies expressing cytokeratin 5 (krt5), p63 and integrin alpha 6 (IGTA6), acquiring more mature basal cell marker, nerve growth factor receptor (NGFR), expression after passaging when cultured on NIH3T3‐J2 feeders or in defined media. iBasal have the capacity for differentiation into a functional, tight junction forming epithelium containing both mucus secreting and motile multiciliated cells at the air liquid interface. In addition, they can form and maintain as spheroids which can also differentiate to generate airway epithelial cells. iBasal can be passaged and maintain a basal cell phenotype similar to that of paired passaged human airway basal cells. Single cell sequence data on iBasal and paired primary and cultured basal cells will provide the ultimate validation of iBasal. Conclusion We have generated iBasal from four independent iPSC lines with functional properties akin to that of primary basal cells. iBasal, therefore, provide the opportunity to generate sufficient functional and gene‐corrected autologous basal cells to develop patient specific, high throughput screening platforms overcoming the current limitations. Support or Funding Information Cystic Fibrosis Foundation FIRTH17XX0, FIRTH15XX1, NIH:NHLBI R01 HL139828‐01, Hastings Foundation This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

Benefits of bronchial epithelial repair by iPSCs in COPD

The Potentially Therapeutic Role of EPAC in Curbing the Process of Idiopathic Pulmonary Fibrosis Via Differential Cellular Pathways

Combined cellular and gene therapy to treat primary ciliary dyskinesia

Intrapulmonary distal airway stem cell transplantation repairs lung injury in chronic obstructive pulmonary disease

Human iPSC-based model of COPD to investigate disease mechanisms, predict SARS-COV-2 outcome and test preventive immunotherapy

Reprogramming of COPD Lung Fibroblasts Through Formation of Induced Pluripotent Stem Cells.

Targeted pre-conditioning and cell transplantation in the murine lower respiratory tract

Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells

Life-long functional regeneration of in vivo airway epithelium by the engraftment of airway basal stem cells

The disruptive effects of COPD exacerbation-associated factors on epithelial repair responses

Recapitulating idiopathic pulmonary fibrosis related alveolar epithelial dysfunction in a human iPSC‐derived air‐liquid interface model

Development of a bronchial epithelium model innervated by sensory neurons from human induced pluripotent stem cells

Ex Vivotissue Perturbations Coupled to Single Cell RNA-seq Reveal Multi-Lineage Cell Circuit Dynamics in Human Lung Fibrogenesis

Promises and Challenges of Cell-Based Therapies to Promote Lung Regeneration in Idiopathic Pulmonary Fibrosis

Modelling bronchial epithelial-fibroblast cross-talk in idiopathic pulmonary fibrosis (IPF) using a human-derived in vitro air liquid interface (ALI) culture

Intratracheal Transplantation Of Endothelial Progenitor Cells Attenuates Smoking-Induced Copd In Mice

Understanding persistent airway obstruction in type 2 severe asthma using human induced pluripotent stem cells (iPSCs)

CRISPR interference interrogation of COPD GWAS genes reveals the functional significance of desmoplakin in iPSC-derived alveolar epithelial cells

Induced Pluripotent Stem Cell-Derived Basal Cells Provide A Novel Source of Multilineage Airway Epithelial Cells

Repairing Mechanisms for Distal Airway Injuries and Related Targeted Therapeutics for Chronic Lung Diseases

High-Throughput Culture Method of Induced Pluripotent Stem Cell-Derived Alveolar Epithelial Cells